Company intelligence / Profile preview

Remiges Ventures

Cambridge, Massachusetts, United Statesremigesventures.com ↗

Ownership: Private
Employees: ~6
Development stage: Phase 2

Overview

Remiges Ventures is a US-Japan cross-border venture capital firm focused on early-stage drug discovery and development. It supports biotech startups developing novel therapeutics across a range of modalities and indications. Its recent investments include companies advancing programs into clinical trials for oncology, neurodegeneration, rare diseases, and gene therapies.

Therapeutic areas: OncologyOphthalmologyNeurology
Modalities: Small moleculeMonoclonal antibodyGene therapyAntibody-drug conjugateRNA therapy
Industry: Investors

Drug pipeline

4 assets

RV-001

Phase 1/2

Indications: Retinitis pigmentosa

3 more assets in the full pipeline.

Request access →

Partnerships

KisoJi Biotechnology with Cancer Research UKQinotto with Lilly on CNS delivery technology

Beyond the preview

Go deeper on Remiges Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Remiges Ventures.

Explore the full profile